Top compounds associated with response to GTF2E1


Feature Type Standardized
Nominal ANOVA
mRNA FK866 CTRPv2 pan-cancer AAC 0.096 0.01
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.082 0.01
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.01
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.01
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.076 0.01
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.02
mRNA vorapaxar CTRPv2 pan-cancer AAC -0.092 0.02
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.02
mRNA BMS-345541 CTRPv2 pan-cancer AAC 0.088 0.02
Download CSV